Condition
Drug-eluting Stent clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Drug-eluting Stent clinical trials that are recruiting, at sites in 3 countries (most in China (2), Switzerland (1), South Korea (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Drug-eluting Stent clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Stents vs Paclitaxel-Coated Balloons for Complex and Small Coronary Vessels | — | Lucerne, Canton of Lucerne | Recruiting | Feb 9, 2026 |
| Evaluating the OSFIT drug-eluting stent for coronary artery stenosis | — | Suwon | Recruiting | Oct 4, 2023 |
| 24-month versus 12-month dual antiplatelet therapy after drug-eluting stent in people with high Lipoprotein(a) | — | Beijing, Beijing Municipality | Recruiting | Aug 28, 2023 |
| Preventing recurrent stroke with drug-eluting stents and aggressive medical treatment | — | Beijing, Beijing Municipality and 17 other locations | Recruiting | Jul 2, 2021 |
All recruiting trials (4)
-
Stents vs Paclitaxel-Coated Balloons for Complex and Small Coronary Vessels
This trial tests whether paclitaxel-coated balloons can match contemporary drug-eluting stents in complex or small coronary artery lesions and compares two paclitaxel-coated balloons against each other.
-
Evaluating the OSFIT drug-eluting stent for coronary artery stenosis
This study is testing whether the OSFIT drug-eluting stent is safe and effective for people with narrowed coronary arteries near the heart's main opening, following them for a year after their procedure.
-
24-month versus 12-month dual antiplatelet therapy after drug-eluting stent in people with high Lipoprotein(a)
This trial will test whether continuing dual antiplatelet therapy for 24 months instead of 12 months lowers the risk of death, heart attack, or stroke in people with high Lipoprotein(a) who had a drug-eluting stent and were event-free at one year.
-
Preventing recurrent stroke with drug-eluting stents and aggressive medical treatment
This study is testing whether using special stents along with strong medical treatment can help prevent strokes in patients with certain types of artery disease in the brain.
Related topics
Quick answers
How many Drug-eluting Stent clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), Switzerland (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.